Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
from 26-NOV-1998 to 03-SEP-1999
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: The test substance purity was known. The screening protocol was standard, but not validated for GLP by the quality assurance unit.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1999
Report date:
1999

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
yes
Remarks:
(3 animals were used at each dose level)
Principles of method if other than guideline:
other: screening protocol similar to OECD guide-line 401 "acute oral toxicity"
GLP compliance:
no
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Cyclopentanone
EC Number:
204-435-9
EC Name:
Cyclopentanone
Cas Number:
120-92-3
Molecular formula:
C5H8O
IUPAC Name:
cyclopentanone

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TESTS ANIMALS
- Source: Harlan Nossan S.r.l, Italy
- Age at study initiation: data not available
- Weight at study initiation: 190-203 g (males), 158-169 g (females)
- Fasting period before study: data not available
- Housing, food consumption, water consumption, acclimation period: data not available

ENVIRONMENTAL CONDITIONS (temperature , humidity, air changes, photoperiod): data not available

In-life dates: data not available

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
other: maize oil
Details on oral exposure:
VEHICULE
- Concentration in vehicle: 50 and 200 mg/mL
- Amount of vehicle: 10 mL/kg
- Justification for choice of vehicle: data not available
- Purity: data not available

MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw

DOSAGE PREPARATION :data not available
Doses:
500 and 2000 mg/kg bw
No. of animals per sex per dose:
3 males (500 mg/kg) and 3 females (2000 mg/kg)
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 day
- Frequency of observations and weighing: data not available
- Necropsy of survivors performed: yes
Statistics:
not applicable

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Remarks on result:
other: 95% Conf. limits: not applicable
Mortality:
no mortality was observed
Clinical signs:
other: Toxic effects were observed: - at 500 and 2000 mg/kg bw, reduced activity, piloerection, hunched posture were observed. - at the lower dose, hair loss was noted following dosing. - at the highest dose, lethargy, part-closed eyes and staining of skin/fu
Gross pathology:
Necropsy showed no abnormalities at 500 and 2000 mg/kg bw doses.

Any other information on results incl. tables

Table 2: body weight changes

Dose level

Animal

Body weight (g) on Day:

Change in body weight

(mg/kg)

Number

1

15

Day 1-15

182

190

293

103

500

184

195

316

121

186

203

315

112

181

159

188

29

2000

183

158

201

43

185

169

197

28

Table 1: Clinical signs and mortality

Dose level

Clinical signs

Mortality

(mg/kg)

500

Reduced activity, piloerection, hunched posture and hair loss noted following dosing. Recovery within 14 days. Necropsy showed no abnormalities.

0/3

2000

Reduced activity/lethargy, piloerection, hunched posture, part-closed eyes and staining of skin/fur noted following dosing. Recovery within 10 days. Necropsy after 14 days showed no abnormalities.

0/3

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
In this study, no mortality were observed in rats (males and females) at the 2 administred doses
of cyclopentanone (500 and 2000 mg/kg).
Executive summary:

In an acute oral toxicity study (Nunziata A, 1999), groups of male and female Sprague-Dawley rats (3/group) were given a single oral dose of cyclopentanone (99.8% purity) in maize oil at doses of 500 and 2000 mg/kg bw and observed for 14 days.
Oral LD50 Combined > 2000mg/kg bw (no mortality was observed)

Cyclopentanone is not classified for acute oral toxicity based on the LD50 identify in male and female rats.